Cryoballoon Ablation With the POLARx FIT or the Arctic Front Advance Pro for Paroxysmal Atrial Fibrillation: A Health Economic Analysis
# Background Pulmonary vein isolation (PVI) is the main ablation strategy for the treatment of paroxysmal atrial fibrillation. Different technologies are available for PVI, including various cryoballoon catheters (CB-A). Compared with the Arctic Front Advance Pro™, the novel POLARx FIT™ CB-A might r...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2025-04-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/001c.133223 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849336032419381248 |
|---|---|
| author | Luigi Pannone Steffen Uffenorde Antonia Bosworth Smith Domenico Giovanni Della Rocca Pasquale Vergara Ioannis Doundoulakis Antonio Sorgente Alvise Del Monte Giacomo Talevi Ingrid Overeinder Gezim Bala Alexandre Almorad Erwin Ströker Juan Sieira Ali Gharaviri Mark La Meir Pedro Brugada Andrea Sarkozy Gian Battista Chierchia Carlo de Asmundis |
| author_facet | Luigi Pannone Steffen Uffenorde Antonia Bosworth Smith Domenico Giovanni Della Rocca Pasquale Vergara Ioannis Doundoulakis Antonio Sorgente Alvise Del Monte Giacomo Talevi Ingrid Overeinder Gezim Bala Alexandre Almorad Erwin Ströker Juan Sieira Ali Gharaviri Mark La Meir Pedro Brugada Andrea Sarkozy Gian Battista Chierchia Carlo de Asmundis |
| author_sort | Luigi Pannone |
| collection | DOAJ |
| description | # Background
Pulmonary vein isolation (PVI) is the main ablation strategy for the treatment of paroxysmal atrial fibrillation. Different technologies are available for PVI, including various cryoballoon catheters (CB-A). Compared with the Arctic Front Advance Pro™, the novel POLARx FIT™ CB-A might reduce costs for atrial fibrillation ablation.
# Objective
The aim of this study is to perform a health economic evaluation of two cryoballoon systems for PVI procedures.
# Methods
All patients undergoing their first PVI procedure with POLARx FIT™ CB-A or the Arctic Front Advance Pro™ CB-A were prospectively enrolled. The health economic analysis was performed on the index hospitalization and procedure. The primary safety endpoint included procedure-related adverse events within the index hospitalization. A decision tree model was built to estimate downstream costs.
# Results
A total of 80 patients with paroxysmal atrial fibrillation undergoing PVI were analyzed, with 40 patients in each arm. Compared with the Arctic Front Advance Pro™ CB-A, POLARx FIT™ CB-A showed a lower procedure time, left-atrium dwell time, and fluoroscopy time. The complication rate was low (6.3%) and included 3 reversible phrenic nerve palsies in the POLARx FIT™ CB-A group vs 2 in the Arctic Front Advance Pro™ CB-A group. Compared with the Arctic Front Advance Pro, the POLARx FIT™ CB-A was associated with lower procedural costs (€2069.7 ± €165.2 vs €2239.5 ± €366.0; _P_ =.009).
# Conclusion
The POLARx FIT™ CB-A was associated with a shorter procedure time, translating into lower procedural costs, compared with the Arctic Front Advance Pro. Complications were rare and comparable between the two technologies. |
| format | Article |
| id | doaj-art-1586c6cdaed2426184040eaf1fa7bced |
| institution | Kabale University |
| issn | 2327-2236 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Columbia Data Analytics, LLC |
| record_format | Article |
| series | Journal of Health Economics and Outcomes Research |
| spelling | doaj-art-1586c6cdaed2426184040eaf1fa7bced2025-08-20T03:45:06ZengColumbia Data Analytics, LLCJournal of Health Economics and Outcomes Research2327-22362025-04-0112110.36469/001c.133223Cryoballoon Ablation With the POLARx FIT or the Arctic Front Advance Pro for Paroxysmal Atrial Fibrillation: A Health Economic AnalysisLuigi PannoneSteffen UffenordeAntonia Bosworth SmithDomenico Giovanni Della RoccaPasquale VergaraIoannis DoundoulakisAntonio SorgenteAlvise Del MonteGiacomo TaleviIngrid OvereinderGezim BalaAlexandre AlmoradErwin StrökerJuan SieiraAli GharaviriMark La MeirPedro BrugadaAndrea SarkozyGian Battista ChierchiaCarlo de Asmundis# Background Pulmonary vein isolation (PVI) is the main ablation strategy for the treatment of paroxysmal atrial fibrillation. Different technologies are available for PVI, including various cryoballoon catheters (CB-A). Compared with the Arctic Front Advance Pro™, the novel POLARx FIT™ CB-A might reduce costs for atrial fibrillation ablation. # Objective The aim of this study is to perform a health economic evaluation of two cryoballoon systems for PVI procedures. # Methods All patients undergoing their first PVI procedure with POLARx FIT™ CB-A or the Arctic Front Advance Pro™ CB-A were prospectively enrolled. The health economic analysis was performed on the index hospitalization and procedure. The primary safety endpoint included procedure-related adverse events within the index hospitalization. A decision tree model was built to estimate downstream costs. # Results A total of 80 patients with paroxysmal atrial fibrillation undergoing PVI were analyzed, with 40 patients in each arm. Compared with the Arctic Front Advance Pro™ CB-A, POLARx FIT™ CB-A showed a lower procedure time, left-atrium dwell time, and fluoroscopy time. The complication rate was low (6.3%) and included 3 reversible phrenic nerve palsies in the POLARx FIT™ CB-A group vs 2 in the Arctic Front Advance Pro™ CB-A group. Compared with the Arctic Front Advance Pro, the POLARx FIT™ CB-A was associated with lower procedural costs (€2069.7 ± €165.2 vs €2239.5 ± €366.0; _P_ =.009). # Conclusion The POLARx FIT™ CB-A was associated with a shorter procedure time, translating into lower procedural costs, compared with the Arctic Front Advance Pro. Complications were rare and comparable between the two technologies.https://doi.org/10.36469/001c.133223 |
| spellingShingle | Luigi Pannone Steffen Uffenorde Antonia Bosworth Smith Domenico Giovanni Della Rocca Pasquale Vergara Ioannis Doundoulakis Antonio Sorgente Alvise Del Monte Giacomo Talevi Ingrid Overeinder Gezim Bala Alexandre Almorad Erwin Ströker Juan Sieira Ali Gharaviri Mark La Meir Pedro Brugada Andrea Sarkozy Gian Battista Chierchia Carlo de Asmundis Cryoballoon Ablation With the POLARx FIT or the Arctic Front Advance Pro for Paroxysmal Atrial Fibrillation: A Health Economic Analysis Journal of Health Economics and Outcomes Research |
| title | Cryoballoon Ablation With the POLARx FIT or the Arctic Front Advance Pro for Paroxysmal Atrial Fibrillation: A Health Economic Analysis |
| title_full | Cryoballoon Ablation With the POLARx FIT or the Arctic Front Advance Pro for Paroxysmal Atrial Fibrillation: A Health Economic Analysis |
| title_fullStr | Cryoballoon Ablation With the POLARx FIT or the Arctic Front Advance Pro for Paroxysmal Atrial Fibrillation: A Health Economic Analysis |
| title_full_unstemmed | Cryoballoon Ablation With the POLARx FIT or the Arctic Front Advance Pro for Paroxysmal Atrial Fibrillation: A Health Economic Analysis |
| title_short | Cryoballoon Ablation With the POLARx FIT or the Arctic Front Advance Pro for Paroxysmal Atrial Fibrillation: A Health Economic Analysis |
| title_sort | cryoballoon ablation with the polarx fit or the arctic front advance pro for paroxysmal atrial fibrillation a health economic analysis |
| url | https://doi.org/10.36469/001c.133223 |
| work_keys_str_mv | AT luigipannone cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT steffenuffenorde cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT antoniabosworthsmith cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT domenicogiovannidellarocca cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT pasqualevergara cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT ioannisdoundoulakis cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT antoniosorgente cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT alvisedelmonte cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT giacomotalevi cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT ingridovereinder cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT gezimbala cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT alexandrealmorad cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT erwinstroker cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT juansieira cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT aligharaviri cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT marklameir cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT pedrobrugada cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT andreasarkozy cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT gianbattistachierchia cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis AT carlodeasmundis cryoballoonablationwiththepolarxfitorthearcticfrontadvanceproforparoxysmalatrialfibrillationahealtheconomicanalysis |